ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 50 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | +123.1% | 72,500 | +140.1% | 0.02% | +183.3% |
| Q1 2019 | $108,000 | -6.9% | 30,200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $116,000 | -48.9% | 30,200 | +25.6% | 0.01% | -33.3% |
| Q3 2018 | $227,000 | -53.6% | 24,050 | -64.1% | 0.01% | -52.6% |
| Q2 2018 | $489,000 | +34.7% | 66,965 | -7.6% | 0.02% | +58.3% |
| Q1 2018 | $363,000 | -13.4% | 72,500 | -12.7% | 0.01% | 0.0% |
| Q4 2017 | $419,000 | +437.2% | 83,000 | +264.0% | 0.01% | +140.0% |
| Q3 2016 | $78,000 | -25.7% | 22,800 | -24.5% | 0.01% | -37.5% |
| Q2 2016 | $105,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |